YU41678B - Process for obtaining spiro-polycyclic imidazolidinedione derivatives - Google Patents

Process for obtaining spiro-polycyclic imidazolidinedione derivatives

Info

Publication number
YU41678B
YU41678B YU2773/79A YU277379A YU41678B YU 41678 B YU41678 B YU 41678B YU 2773/79 A YU2773/79 A YU 2773/79A YU 277379 A YU277379 A YU 277379A YU 41678 B YU41678 B YU 41678B
Authority
YU
Yugoslavia
Prior art keywords
polycyclic
spiro
obtaining
imidazolidinedione derivatives
imidazolidinedione
Prior art date
Application number
YU2773/79A
Other languages
English (en)
Other versions
YU277379A (en
Inventor
R Sarges
J Belletire
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU277379A publication Critical patent/YU277379A/xx
Publication of YU41678B publication Critical patent/YU41678B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
YU2773/79A 1978-11-16 1979-11-12 Process for obtaining spiro-polycyclic imidazolidinedione derivatives YU41678B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/961,335 US4181728A (en) 1978-11-16 1978-11-16 Spiro-polycyclicimidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
YU277379A YU277379A (en) 1983-01-21
YU41678B true YU41678B (en) 1987-12-31

Family

ID=25504341

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2773/79A YU41678B (en) 1978-11-16 1979-11-12 Process for obtaining spiro-polycyclic imidazolidinedione derivatives

Country Status (23)

Country Link
US (1) US4181728A (zh)
JP (2) JPS6052157B2 (zh)
AR (1) AR222052A1 (zh)
AT (1) AT369742B (zh)
AU (1) AU515301B2 (zh)
BE (1) BE880065A (zh)
CA (1) CA1125294A (zh)
CH (1) CH642358A5 (zh)
DE (1) DE2946037A1 (zh)
DK (1) DK484479A (zh)
ES (1) ES486007A1 (zh)
FI (1) FI66385C (zh)
FR (1) FR2441627A1 (zh)
GB (1) GB2038315B (zh)
IE (1) IE49116B1 (zh)
IL (1) IL58730A (zh)
IT (1) IT1127231B (zh)
LU (1) LU81890A1 (zh)
NL (1) NL177689C (zh)
PH (1) PH15672A (zh)
PT (1) PT70452A (zh)
SE (1) SE447731B (zh)
YU (1) YU41678B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
ATE10940T1 (de) * 1981-05-12 1985-01-15 Imperial Chemical Industries Plc Pyrrolderivate.
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
JPS59500618A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
DE3342933A1 (de) * 1983-11-26 1985-06-05 Horst G. 5190 Stolberg Schumann Regalfoerderzeug
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4576143A (en) * 1984-10-05 1986-03-18 Clark Iii William T Method of immune modification by means of extracorporeal irradiation of the blood
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
JPS6372140U (zh) * 1986-10-29 1988-05-14
JPS63119451U (zh) * 1987-01-30 1988-08-02
WO1992000071A1 (en) * 1989-02-10 1992-01-09 Washington Research Foundation Immunoregulatory agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1032257B (de) * 1954-05-27 1958-06-19 Cutter Lab Verfahren zur Herstellung neuer Hydantoine
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4078064A (en) * 1976-08-18 1978-03-07 E. R. Squibb & Sons, Inc. 8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Also Published As

Publication number Publication date
JPS5589268A (en) 1980-07-05
JPS6144868B2 (zh) 1986-10-04
SE7909439L (sv) 1980-05-17
US4181728A (en) 1980-01-01
FI66385B (fi) 1984-06-29
IL58730A0 (en) 1980-02-29
AT369742B (de) 1983-01-25
IE792184L (en) 1980-05-16
GB2038315A (en) 1980-07-23
AU5288079A (en) 1980-05-22
IT1127231B (it) 1986-05-21
JPS60120870A (ja) 1985-06-28
FI793586A (fi) 1980-05-17
YU277379A (en) 1983-01-21
DK484479A (da) 1980-05-17
NL177689C (nl) 1985-11-01
DE2946037A1 (de) 1980-05-22
PH15672A (en) 1983-03-11
FR2441627B1 (zh) 1983-06-03
JPS6052157B2 (ja) 1985-11-18
FR2441627A1 (fr) 1980-06-13
BE880065A (fr) 1980-05-16
GB2038315B (en) 1982-08-11
AR222052A1 (es) 1981-04-15
NL7908352A (nl) 1980-05-20
ES486007A1 (es) 1980-09-01
CA1125294A (en) 1982-06-08
ATA729779A (de) 1982-06-15
CH642358A5 (fr) 1984-04-13
FI66385C (fi) 1984-10-10
SE447731B (sv) 1986-12-08
PT70452A (en) 1979-12-01
AU515301B2 (en) 1981-03-26
IT7927311A0 (it) 1979-11-15
NL177689B (nl) 1985-06-03
LU81890A1 (fr) 1980-06-05
IE49116B1 (en) 1985-08-07
IL58730A (en) 1984-01-31

Similar Documents

Publication Publication Date Title
YU43532B (en) Process for obtaining carboxyalkyldipeptides derivatives
YU5079A (en) Process for obtaining new 4-amino-5-alkyl-sulfony-orthoismide derivatives
HU179424B (en) Process for producing imidazo-quinasoline derivatives
YU160479A (en) Process for preparing 3-amino-propoxy-aryl derivatives
YU16183A (en) Process for obtaining new heterocyclic derivatives
YU93179A (en) Process for obtaining 4-deacetyl-vinca-leublastin c-3-carboxhydrazide
YU177879A (en) Process for obtaining imidazole derivatives
YU277379A (en) Process for obtaining spiro-polycyclic imidazolidinedione derivatives
RO82526B (ro) Procedeu de obtinere a unor derivati de flavan
YU84179A (en) Process for obtaining 2-aminopyridone derivatives
YU80179A (en) Process for obtaining lysergol derivatives
HU178089B (en) Process for producing imidazo-quinoxaline derivatives
YU42653B (en) Process for obtaining n-benzylhaloacetamide derivatives
YU241279A (en) Process for obtaining 2-chlorosulfinyl-azetidine-4-one
HU178589B (en) Process for producing pyridie derivatives
YU73579A (en) Process for obtaining steroid-spiro-oxazolidinone derivatives
YU112279A (en) Process for obtaining substituted dibenzylethers
HU178357B (en) Process for producing thioalkanoiyl-pyrrolidine-carboxaldehyde derivatives
YU86879A (en) Process for obtaining 17-beta-carboxy-5-androstane-3-one
YU236180A (en) Process for obtaining 15-sulfonamido-prostaglandin derivatives
HU178113B (en) Process for producing n-bracket-1-methyl-2-pyrolidinyl-methyl-bracket closed-2-3-dimethoxy-5-methyl-sulfamoyl-benzamide derivatives
YU250379A (en) Process for obtaining 2-amino-or 2-thio-substituted derivatives of 4,5-diphenyl-oxazole
YU109679A (en) Process for preparing n-cyano-azomethine derivatives
PT70602A (en) Process for preparing 7alpha-methoxycephalosporin derivatives
PT70003A (en) Process for preparing oxadiazolotriazine derivatives